Submitted by Anonymous (not verified) on 27 October 2026 - 16:40
Human medicines European public assessment report (EPAR): Hemlibra, emicizumab, Date of authorisation: 23/02/2018, Revision: 21, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Hemlibra, emicizumab, Date of authorisation: 23/02/2018, Revision: 21, Status: Authorised